Nevada Chapter of the American College of Cardiology

Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure
The goal of the FINEARTS-HF trial was to determine the efficacy and safety of the nonsteroidal mineralocorticoid antagonist finerenone in patients with heart failure (HF) with preserved or mildly reduced left ventricular ejection fraction (LVEF).
Aspirin in Patients With DES Undergoing Noncardiac Surgery
Is there a benefit to perioperative continuation of aspirin in patients with coronary drug-eluting stents (DES) undergoing noncardiac surgery?
Community-Based Trial of Compression Tights in POTS
What is the ability of commercially available waist-high compression (WHC) garments to reduce heart rate and improve symptoms in patients with postural orthostatic tachycardia syndrome (POTS) in a community setting?
ACC 2025 Medicare Physician Fee Schedule Final Rule Calculator Now Available
Work, practice, expense and liability relative value units (RVUs) are updated annually through the Centers for Medicare and Medicaid Services' Medicare Physician Fee Schedule (PFS) rulemaking.
To Continue or Not Continue: Beta-Blockers Following Acute Myocardial Infarction
Current guidelines regarding beta-blocker use after myocardial infarction (MI) recommend against continuation to improve outcomes after 1 year, in the absence of reduced left ventricular ejection fraction (LVEF;